A team of researchers and clinicians at Geisel and Dartmouth-Hitchcock has begun working together on a National Institutes of Health grant to track the development and spread of COVID-19 variants that are detected in the Upper Valley.
Post Tagged with: "COVID-19"
A team of researchers at Dartmouth’s Geisel School of Medicine, led by Glyn Elwyn, MD, PhD, MSc, and Marie-Anne Durand, PhD, has received a $6.2 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to test approaches that may increase confidence in the COVID-19 vaccine among those working in long-term care facilities.
Discoveries originating in a basic science lab at the Geisel School of Medicine are being used in the newly approved COVID-19 vaccine from the Pfizer/BioNTech partnership.
Researchers at Dartmouth’s Geisel School of Medicine have been awarded $2.4 million in federal funding to support ongoing studies aimed at enhancing American healthcare providers’ response to the COVID-19 pandemic.
A new Dartmouth study in Health Affairs examines how hospital admissions during the rebound from the initial COVID-19 onset varies by age, insurance coverage and socioeconomic groups.
Both first- and second-year Geisel medical students completed their required 14-day quarantines and screening PCR testing per Dartmouth policy. As of this week, we are happy to report that there are no positive tests among our medical or graduate students. Thanks to everyone for their continued commitment to the safety of our community.
New findings from a Dartmouth-led study, published in the August issue of Health Affairs, show that larger, more integrated healthcare systems do not generally deliver better quality care, and urge policy makers to ensure that mergers or acquisitions due to pandemic-associated financial stress adhere to current antitrust law.
A $328,000 National Cancer Institute (NCI) grant will enable researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) to investigate one of the mechanisms that may be responsible for the body’s inability to fight COVID-19.
A new study from the Center for Global Health Equity at Dartmouth revealed key strengths in the rural Northern New England response that contributed to low infection rates and mitigated the impacts on the region’s vulnerable populations.
A new Dartmouth-led paper published in the New England Journal of Medicine highlights that more emphasis should be placed on addressing the inaccuracy of COVID-19 diagnostic tests.